Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2024-05-15

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.3bn reported value +31.2% vs Q4 2023
68positions
62.7%in top 10
18 new 20 added 28 reduced 5 sold out vs Q4 2023

Options: 0 call positions (— notional), 2 put positions ($161.0m notional) – listed below, not included above.

Holdings, Q1 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 1,778,051 $162.6m12.15% 12.15% ReducedShares held: Q2 2023 2.4m, Q3 2023 2.5m, Q4 2023 2.3m, Q1 2024 1.8m -473.5k -473,537 -21.0%
2 GSK PLC SPONSORED ADR GSK GSK 3,771,994 $161.7m12.08% 12.08% AddedShares held: Q2 2023 2.9m, Q3 2023 3.3m, Q4 2023 3.0m, Q1 2024 3.8m +799.0k +799,040 26.9%
3 INSPIRE MED SYS INC COM INSP INSP 420,699 $90.4m6.75% 6.75% AddedShares held: Q2 2023 82.4k, Q3 2023 193.0k, Q4 2023 351.1k, Q1 2024 420.7k +69.6k +69,583 19.8%
4 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 6,025,169 $85.0m6.35% 6.35% ReducedShares held: Q2 2023 7.7m, Q3 2023 7.0m, Q4 2023 6.2m, Q1 2024 6.0m -129.2k -129,185 -2.1%
5 VERA THERAPEUTICS INC CL A VERA VERA 1,823,781 $78.6m5.88% 5.88% ReducedShares held: Q2 2023 1.7m, Q3 2023 1.5m, Q4 2023 1.9m, Q1 2024 1.8m -91.0k -91,049 -4.8%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,133,113 $74.6m5.57% 5.57% ReducedShares held: Q2 2023 2.2m, Q3 2023 2.6m, Q4 2023 3.4m, Q1 2024 3.1m -250.1k -250,131 -7.4%
7 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 251,135 $57.7m4.31% 4.31% AddedShares held: Q2 2023 260.4k, Q3 2023 267.9k, Q4 2023 246.2k, Q1 2024 251.1k +4.9k +4,901 2.0%
8 REVVITY INC COM RVTY RVTY 483,160 $50.7m3.79% 3.79% AddedShares held: Q2 2023 21.3k, Q3 2023 32.7k, Q4 2023 183.1k, Q1 2024 483.2k +300.1k +300,101 163.9%
9 BIO-TECHNE CORP COM TECH TECH 607,687 $42.8m3.20% 3.20% AddedShares held: Q2 2023 342.6k, Q3 2023 385.9k, Q4 2023 465.3k, Q1 2024 607.7k +142.4k +142,380 30.6%
10 HCA HEALTHCARE INC COM HCA HCA 103,821 $34.6m2.59% 2.59% ReducedShares held: Q2 2023 80.7k, Q3 2023 110.1k, Q4 2023 114.8k, Q1 2024 103.8k -11.0k -10,984 -9.6%
11 HEALTHEQUITY INC COM HQY HQY 421,345 $34.4m2.57% 2.57% ReducedShares held: Q2 2023 0, Q3 2023 338.5k, Q4 2023 494.9k, Q1 2024 421.3k -73.6k -73,574 -14.9%
12 PFIZER INC COM PFE PFE 1,102,042 $30.6m2.29% 2.29% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 1.1m
13 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 711,115 $29.8m2.23% 2.23% ReducedShares held: Q2 2023 785.7k, Q3 2023 588.1k, Q4 2023 754.1k, Q1 2024 711.1k -43.0k -42,992 -5.7%
14 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 7,980,641 $27.9m2.09% 2.09% AddedShares held: Q2 2023 7.3m, Q3 2023 7.1m, Q4 2023 7.2m, Q1 2024 8.0m +749.5k +749,515 10.4%
15 SHOCKWAVE MED INC COM SWAV SWAV 80,555 $26.2m1.96% 1.96% AddedShares held: Q2 2023 20.1k, Q3 2023 84.5k, Q4 2023 75.8k, Q1 2024 80.6k +4.7k +4,733 6.2%
16 ARGENX SE SPONSORED ADR ARGX ARGX 54,518 $21.5m1.60% 1.60% ReducedShares held: Q2 2023 4.2k, Q3 2023 4.6k, Q4 2023 85.8k, Q1 2024 54.5k -31.3k -31,314 -36.5%
17 TENET HEALTHCARE CORP COM NEW THC THC 175,631 $18.5m1.38% 1.38% ReducedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 187.3k, Q1 2024 175.6k -11.6k -11,634 -6.2%
18 IONIS PHARMACEUTICALS INC COM IONS IONS 376,438 $16.3m1.22% 1.22% AddedShares held: Q2 2023 241.6k, Q3 2023 252.4k, Q4 2023 324.7k, Q1 2024 376.4k +51.8k +51,784 15.9%
19 VIATRIS INC COM VTRS VTRS 1,316,469 $15.7m1.17% 1.17% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 1.3m
20 VAXCYTE INC COM PCVX PCVX 197,331 $13.5m1.01% 1.01% ReducedShares held: Q2 2023 195.7k, Q3 2023 190.4k, Q4 2023 233.8k, Q1 2024 197.3k -36.5k -36,508 -15.6%
21 HUMANA INC COM HUM HUM 35,532 $12.3m0.92% 0.92% AddedShares held: Q2 2023 11.9k, Q3 2023 18.1k, Q4 2023 1.9k, Q1 2024 35.5k +33.6k +33,618 1756.4%
22 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 411,478 $11.9m0.89% 0.89% ReducedShares held: Q2 2023 114.7k, Q3 2023 286.7k, Q4 2023 538.1k, Q1 2024 411.5k -126.6k -126,596 -23.5%
23 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 263,541 $11.2m0.83% 0.83% AddedShares held: Q2 2023 250.3k, Q3 2023 255.3k, Q4 2023 256.0k, Q1 2024 263.5k +7.6k +7,553 3.0%
24 MANNKIND CORP COM NEW MNKD MNKD 2,391,128 $10.8m0.81% 0.81% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 2.4m
25 DANAHER CORPORATION COM DHR DHR 40,855 $10.2m0.76% 0.76% ReducedShares held: Q2 2023 103.3k, Q3 2023 103.8k, Q4 2023 41.0k, Q1 2024 40.9k -186 -186 -0.5%
26 ELI LILLY & CO COM LLY LLY 12,877 $10.0m0.75% 0.75% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 12.9k
27 ZIMVIE INC COM ZIMV ZIMV 564,498 $9.3m0.70% 0.70% AddedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 546.4k, Q1 2024 564.5k +18.1k +18,054 3.3%
28 GUARDANT HEALTH INC COM GH GH 449,586 $9.3m0.69% 0.69% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 449.6k
29 BROOKDALE SR LIVING INC COM BKD BKD 1,318,765 $8.7m0.65% 0.65% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 1.3m
30 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 353,965 $8.4m0.63% 0.63% ReducedShares held: Q2 2023 692.4k, Q3 2023 660.6k, Q4 2023 374.4k, Q1 2024 354.0k -20.4k -20,439 -5.5%
31 IMMUNOVANT INC COM IMVT IMVT 255,526 $8.3m0.62% 0.62% AddedShares held: Q2 2023 0, Q3 2023 0, Q4 2023 113.8k, Q1 2024 255.5k +141.7k +141,733 124.5%
32 NOVO-NORDISK A S ADR NVO NVO 62,344 $8.0m0.60% 0.60% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 62.3k
33 KARYOPHARM THERAPEUTICS INC COM COM 5,016,320 $7.6m0.57% 0.57% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 5.0m
34 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,426,497 $7.6m0.57% 0.57% ReducedShares held: Q2 2023 1.7m, Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.4m -268.5k -268,524 -15.8%
35 ELEVANCE HEALTH INC COM ELV ELV 14,393 $7.5m0.56% 0.56% ReducedShares held: Q2 2023 2.3k, Q3 2023 21.7k, Q4 2023 15.1k, Q1 2024 14.4k -701 -701 -4.6%
36 TRAVERE THERAPEUTICS INC COM TVTX TVTX 955,618 $7.4m0.55% 0.55% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 955.6k
37 CENTENE CORP DEL COM CNC CNC 92,786 $7.3m0.54% 0.54% ReducedShares held: Q2 2023 152.7k, Q3 2023 190.6k, Q4 2023 97.2k, Q1 2024 92.8k -4.4k -4,412 -4.5%
38 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,432,427 $7.3m0.54% 0.54% ReducedShares held: Q2 2023 2.4m, Q3 2023 2.5m, Q4 2023 1.5m, Q1 2024 1.4m -96.6k -96,620 -6.3%
39 GOSSAMER BIO INC COM GOSS GOSS 5,994,472 $7.1m0.53% 0.53% ReducedShares held: Q2 2023 749.7k, Q3 2023 4.4m, Q4 2023 6.4m, Q1 2024 6.0m -438.2k -438,243 -6.8%
40 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 2,325,591 $6.7m0.50% 0.50% ReducedShares held: Q2 2023 0, Q3 2023 1.7m, Q4 2023 3.8m, Q1 2024 2.3m -1.5m -1,455,123 -38.5%
41 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,177,678 $6.3m0.47% 0.47% AddedShares held: Q2 2023 0, Q3 2023 1.5m, Q4 2023 1.1m, Q1 2024 1.2m +38.6k +38,567 3.4%
42 SUTRO BIOPHARMA INC COM COM 1,091,419 $6.2m0.46% 0.46% AddedShares held: Q2 2023 747.9k, Q3 2023 769.6k, Q4 2023 1.1m, Q1 2024 1.1m +35.0k +34,958 3.3%
43 LIQUIDIA CORPORATION COM NEW LQDA LQDA 396,187 $5.8m0.44% 0.44% ReducedShares held: Q2 2023 925.4k, Q3 2023 1.4m, Q4 2023 688.9k, Q1 2024 396.2k -292.7k -292,739 -42.5%
44 NEVRO CORP COM NVRO NVRO 389,663 $5.6m0.42% 0.42% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 389.7k
45 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 6,212,748 $5.5m0.41% 0.41% AddedShares held: Q2 2023 10.5m, Q3 2023 8.4m, Q4 2023 6.1m, Q1 2024 6.2m +117.2k +117,243 1.9%
46 MERUS N V COM MRUS MRUS 119,482 $5.4m0.40% 0.40% AddedShares held: Q2 2023 131.2k, Q3 2023 134.0k, Q4 2023 115.7k, Q1 2024 119.5k +3.8k +3,756 3.2%
47 ICON PLC SHS ICLR ICLR 15,347 $5.2m0.39% 0.39% ReducedShares held: Q2 2023 71.7k, Q3 2023 21.0k, Q4 2023 15.4k, Q1 2024 15.3k -70 -70 -0.5%
48 WATERS CORP COM WAT WAT 13,628 $4.7m0.35% 0.35% ReducedShares held: Q2 2023 10.9k, Q3 2023 23.1k, Q4 2023 27.7k, Q1 2024 13.6k -14.1k -14,091 -50.8%
49 STOKE THERAPEUTICS INC COM STOK STOK 290,000 $3.9m0.29% 0.29% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 290.0k
50 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 88,934 $3.5m0.26% 0.26% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 88.9k
51 KRYSTAL BIOTECH INC COM KRYS KRYS 18,557 $3.3m0.25% 0.25% ReducedShares held: Q2 2023 106.5k, Q3 2023 108.8k, Q4 2023 80.8k, Q1 2024 18.6k -62.2k -62,241 -77.0%
52 ALECTOR INC COM ALEC ALEC 536,171 $3.2m0.24% 0.24% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 536.2k
53 AVANTOR INC COM AVTR AVTR 125,394 $3.2m0.24% 0.24% ReducedShares held: Q2 2023 0, Q3 2023 84.5k, Q4 2023 126.0k, Q1 2024 125.4k -570 -570 -0.5%
54 IQVIA HLDGS INC COM IQV IQV 12,178 $3.1m0.23% 0.23% ReducedShares held: Q2 2023 18.7k, Q3 2023 23.0k, Q4 2023 12.3k, Q1 2024 12.2k -85 -85 -0.7%
55 MORPHOSYS AG SPONSORED ADS SPONSORED ADS 165,924 $3.0m0.22% 0.22% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 165.9k
56 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 142,075 $2.5m0.19% 0.19% AddedShares held: Q2 2023 0, Q3 2023 443.3k, Q4 2023 137.3k, Q1 2024 142.1k +4.7k +4,732 3.5%
57 MOLINA HEALTHCARE INC COM MOH MOH 5,828 $2.4m0.18% 0.18% ReducedShares held: Q2 2023 21.3k, Q3 2023 12.2k, Q4 2023 6.1k, Q1 2024 5.8k -289 -289 -4.7%
58 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 97,065 $2.3m0.17% 0.17% AddedShares held: Q2 2023 90.0k, Q3 2023 90.0k, Q4 2023 93.7k, Q1 2024 97.1k +3.3k +3,338 3.6%
59 INFLARX NV COM IFRX IFRX 1,305,140 $2.0m0.15% 0.15% UnchangedShares held: Q2 2023 1.9m, Q3 2023 1.7m, Q4 2023 1.3m, Q1 2024 1.3m
60 VIKING THERAPEUTICS INC COM VKTX VKTX 22,818 $1.9m0.14% 0.14% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 22.8k
61 TERNS PHARMACEUTICALS INC COM COM 283,034 $1.9m0.14% 0.14% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 283.0k
62 AEROVATE THERAPEUTICS INC COM COM 54,150 $1.6m0.12% 0.12% AddedShares held: Q2 2023 50.2k, Q3 2023 50.2k, Q4 2023 50.2k, Q1 2024 54.1k +3.9k +3,908 7.8%
63 CUREVAC N V COM CVAC CVAC 515,691 $1.6m0.12% 0.12% AddedShares held: Q2 2023 357.3k, Q3 2023 516.8k, Q4 2023 496.9k, Q1 2024 515.7k +18.8k +18,779 3.8%
64 REPLIGEN CORP COM RGEN RGEN 8,237 $1.5m0.11% 0.11% ReducedShares held: Q2 2023 66.1k, Q3 2023 16.2k, Q4 2023 10.0k, Q1 2024 8.2k -1.7k -1,747 -17.5%
65 SERES THERAPEUTICS INC COM COM 1,388,944 $1.1m0.08% 0.08% ReducedShares held: Q2 2023 3.1m, Q3 2023 2.4m, Q4 2023 1.8m, Q1 2024 1.4m -364.6k -364,594 -20.8%
66 AFFIMED N V ORDINARY SHS NEW AFMDQ AFMDQ 166,460 $882.2k0.07% 0.07% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 166.5k
67 VINCERX PHARMA INC COM NEW COM NEW 79,588 $402.7k0.03% 0.03% NewShares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 79.6k
68 AC IMMUNE SA SHS ACIU ACIU 124,589 $368.8k0.03% 0.03% UnchangedShares held: Q2 2023 124.6k, Q3 2023 124.6k, Q4 2023 124.6k, Q1 2024 124.6k

Sold out since Q4 2023

SecurityTickerShares held beforeValue then
IMMUNOGEN INC IMGN IMGN 748,950 $22.2m749.0k shares
ILLUMINA INC ILMN ILMN 86,614 $12.1m86.6k shares
AGILENT TECHNOLOGIES INC A A 37,854 $5.3m37.9k shares
BIOHAVEN LTD BHVN BHVN 66,898 $2.9m66.9k shares
AFFIMED N V 1,676,684 $1.0m1.7m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 326,800 $145.1m326.8k shares Added
SPDR S&P 500 ETF TR SPY · Put SPYPut 30,300 $15.8m30.3k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17